Weiqi Chen

2.2k total citations · 1 hit paper
70 papers, 1.1k citations indexed

About

Weiqi Chen is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weiqi Chen has authored 70 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 26 papers in Cardiology and Cardiovascular Medicine and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weiqi Chen's work include Acute Ischemic Stroke Management (37 papers), Antiplatelet Therapy and Cardiovascular Diseases (25 papers) and Cerebrovascular and Carotid Artery Diseases (16 papers). Weiqi Chen is often cited by papers focused on Acute Ischemic Stroke Management (37 papers), Antiplatelet Therapy and Cardiovascular Diseases (25 papers) and Cerebrovascular and Carotid Artery Diseases (16 papers). Weiqi Chen collaborates with scholars based in China, United States and Canada. Weiqi Chen's co-authors include Yuesong Pan, Yongjun Wang, Liping Liu, Xingquan Zhao, Yilong Wang, Lian Huang, Huaguang Zheng, Hao Li, Yilong Wang and Hongyu Zhou and has published in prestigious journals such as New England Journal of Medicine, Circulation and Neurology.

In The Last Decade

Weiqi Chen

64 papers receiving 1.1k citations

Hit Papers

Chinese Stroke Association guidelines for clinical manage... 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiqi Chen China 16 544 399 197 165 157 70 1.1k
Djordje Radak Serbia 20 300 0.6× 363 0.9× 590 3.0× 131 0.8× 261 1.7× 122 1.6k
Liyuan Han China 14 425 0.8× 152 0.4× 126 0.6× 27 0.2× 89 0.6× 39 1.2k
Daniel Kanter United States 10 310 0.6× 134 0.3× 157 0.8× 58 0.4× 331 2.1× 15 895
Fabio Fimiani Italy 17 256 0.5× 413 1.0× 77 0.4× 43 0.3× 42 0.3× 46 1.4k
Zhaosu Wu China 11 318 0.6× 405 1.0× 114 0.6× 18 0.1× 65 0.4× 18 1.1k
Enrica Golia Italy 18 291 0.5× 912 2.3× 180 0.9× 65 0.4× 33 0.2× 33 1.7k
Silke Wiedmann Germany 17 357 0.7× 98 0.2× 93 0.5× 63 0.4× 91 0.6× 36 784
Francesco Natale Italy 18 248 0.5× 820 2.1× 239 1.2× 32 0.2× 162 1.0× 64 1.7k
John David L. Nolen United States 9 380 0.7× 128 0.3× 92 0.5× 16 0.1× 85 0.5× 14 945

Countries citing papers authored by Weiqi Chen

Since Specialization
Citations

This map shows the geographic impact of Weiqi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqi Chen more than expected).

Fields of papers citing papers by Weiqi Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiqi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqi Chen. The network helps show where Weiqi Chen may publish in the future.

Co-authorship network of co-authors of Weiqi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Weiqi Chen. A scholar is included among the top collaborators of Weiqi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiqi Chen. Weiqi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Min, Ying Gao, Y. Wang, et al.. (2025). Does the Burden of CSVD Modify the Efficacy of Dual Antiplatelet Therapy?: A Post Hoc Analysis of the INSPIRES Trial. Stroke. 56(6). 1376–1387. 1 indexed citations
2.
Jiang, Qi, Han Hu, Weiqi Chen, et al.. (2025). Intrinsically flame-retardant and biodegradable DDP-based adhesives for wet environments. Chemical Engineering Journal. 515. 163938–163938. 1 indexed citations
3.
Wang, Y., Yuesong Pan, Xiaoling Liao, et al.. (2024). Cerebral small vessel disease was associated with the prognosis in ischemic stroke with atrial fibrillation. CNS Neuroscience & Therapeutics. 30(10). e70052–e70052. 2 indexed citations
4.
Zhao, Jinguo, Ying Gao, Weiqi Chen, et al.. (2024). Clopidogrel and Aspirin Initiated Between 24 to 72 Hours for Mild Ischemic Stroke. JAMA Network Open. 7(9). e2431938–e2431938. 2 indexed citations
5.
Gao, Ying, Weiqi Chen, S. Claiborne Johnston, et al.. (2024). Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke Stratified by Risk Profile: A Post Hoc Analysis. Stroke. 56(1). 46–55. 1 indexed citations
7.
Zhou, Hongyu, Yuesong Pan, Weiqi Chen, et al.. (2023). Smokers with Elevated Glycated Albumin Could Not Benefit from Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack. Cerebrovascular Diseases. 53(2). 144–151. 1 indexed citations
8.
Wang, Y., Xueli Cai, Hang Li, et al.. (2023). Association of intracranial atherosclerosis with cerebral small vessel disease in a community‐based population. European Journal of Neurology. 30(9). 2700–2712. 6 indexed citations
9.
Liao, Xiaoling, Shuo Feng, Yuesong Pan, et al.. (2023). Tirofiban combined with Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction (STRATEGY): protocol for a multicentre, randomised controlled trial. Stroke and Vascular Neurology. 9(1). 75–81. 6 indexed citations
10.
11.
Chen, Weiqi, et al.. (2022). Nitrate Metabolism and Ischemic Cerebrovascular Disease: A Narrative Review. Frontiers in Neurology. 13. 735181–735181. 5 indexed citations
12.
Chen, Weiqi, Xia Meng, Yuesong Pan, et al.. (2022). Association of PCSK9 levels and genetic polymorphisms with stroke recurrence and functional outcome after acute ischemic stroke. Annals of Translational Medicine. 10(13). 729–729. 4 indexed citations
13.
Wu, Guizhen, et al.. (2022). Impact of the COVID-19 epidemic anxiety on college students' employment confidence and employment situation perception in China. Frontiers in Psychology. 13. 980634–980634. 30 indexed citations
15.
Liu, Liping, Weiqi Chen, Hongyu Zhou, et al.. (2020). Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases. Stroke and Vascular Neurology. 5(2). 159–176. 213 indexed citations breakdown →
16.
Zhou, Hongyu, Weiqi Chen, Yuesong Pan, et al.. (2020). Effect of sex differences on prognosis of intravenous thrombolysis: data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China). Stroke and Vascular Neurology. 6(1). 10–15. 12 indexed citations
17.
Yang, Yingying, Weiqi Chen, Yuesong Pan, et al.. (2020). Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA. Frontiers in Neurology. 11. 534–534. 6 indexed citations
18.
Chen, Weiqi, Yuesong Pan, Xingquan Zhao, et al.. (2018). The max‐intracerebral hemorrhage score predicts long‐term outcome of intracerebral hemorrhage. CNS Neuroscience & Therapeutics. 24(12). 1149–1155. 17 indexed citations
19.
Pan, Yuesong, et al.. (2018). THRIVE‐c score predicts clinical outcomes in Chinese patients after thrombolysis. Brain and Behavior. 8(2). e00927–e00927. 9 indexed citations
20.
Lin, Yi, Anxin Wang, Jiejie Li, et al.. (2017). Impact of Glycemic Control on Efficacy of Clopidogrel in Transient Ischemic Attack or Minor Stroke Patients With CYP2C19 Genetic Variants. Stroke. 48(4). 998–1004. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026